It can be used to select patients more likely to respond to treatment but also PDL1‐negative tumors can respond, and its predictive ability seems to be more pronounced in AD than in SCC (Borghaei et al., 2015; Brahmer et al., 2015). The gene discussed is CD274; the disease is Alzheimer disease.